ProSciento Appoints Dr. Michael Grimm as Chief Medical Officer Read More »
ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH) Read More »
View Our Presentation
Clinical Research Strategies to Drive Advances in Obesity Drug Development Read More »
NASH Patient Access and Screening Strategies or NASH PASS: An epidemiological, multicenter, prospective screening registry for adults with nonalcoholic steatohepatitis Read More »
Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption Read More »
